간행물

대한간학회> Clinical and Molecular Hepatology(대한간학회지)

Clinical and Molecular Hepatology(대한간학회지) update

Clinical and Molecular Hepatology (CMH)

  • : 대한간학회
  • : 의약학분야  >  내과학
  • : KCI등재
  • : SCOPUS
  • : 연속간행물
  • : 계간
  • : 2287-2728
  • : 2287-285x
  • : 대한간학회지()→Korean Journal of Hepatology(2004~)→대한간학회지(2012~)

수록정보
수록범위 : 1권1호(1995)~26권4호(2020) |수록논문 수 : 4,676
Clinical and Molecular Hepatology(대한간학회지)
26권4호(2020년 10월) 수록논문
최근 권호 논문
| | | |

KCI등재 SCOPUS

1Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH

저자 : Theresa J. Hydes , Sujan Ravi , Rohit Loomba , Meagan E. Gray

발행기관 : 대한간학회 간행물 : Clinical and Molecular Hepatology(대한간학회지) 26권 4호 발행 연도 : 2020 페이지 : pp. 383-400 (18 pages)

다운로드

(기관인증 필요)

초록보기

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming a global epidemic as a result of the rising rates of obesity and metabolic disease. Emerging data suggest weight loss of ≥10% overall body weight is beneficial in resolving steatosis and reversing fibrosis. Prospective trials comparing various diets are limited by lack of sufficient power as well as pre- and post-treatment histopathology, and therefore no specific diet is recommended at this time. In this narrative review we examine the pathophysiology behind specific macronutrient components that can either promote or reverse NAFLD to help inform more specific dietary recommendations. Overall, the data supports reducing saturated fat, refined carbohydrates, and red and processed meats in the diet, and increasing the consumption of plant-based foods. Diets that incorporate these recommendations include plant-based diets such as the Dietary Approaches to Stop Hypertension, Mediterranean, vegetarian, and vegan diets. (Clin Mol Hepatol 2020;26:383-400)

KCI등재 SCOPUS

2Liver graft from donation after circulatory death donor: Real practice to improve graft viability

저자 : Koji Hashimoto

발행기관 : 대한간학회 간행물 : Clinical and Molecular Hepatology(대한간학회지) 26권 4호 발행 연도 : 2020 페이지 : pp. 401-410 (10 pages)

다운로드

(기관인증 필요)

초록보기

Donation after circulatory death (DCD) is an increasing source of liver grafts for transplantation, yet outcomes have been inferior compared to donation after brain death liver transplantation. These worse outcomes are mainly due to the severe graft injury resulting from mandatory warm ischemia during DCD organ recovery. New evidence, however, indicates that improved donor selection and surgical techniques can decrease the risk of graft failure and ischemic cholangiopathy (IC). Under current best practices, DCD organs are retrieved with the super-rapid technique, optimizing timing and protecting the liver graft from detrimental warm ischemia. Graft viability is influenced by both the quantity and quality of warm ischemia, which is unique to each donor and causes various degrees of pathophysiologic consequences. Evidence also shows that the choice of preservation solution and premortem heparin administration influences graft viability. Additionally, although the precise mechanism of IC remains unknown, stasis of blood during donor warm ischemia may cause the formation of microthrombi in the peribiliary vascular plexus and ischemia of the bile duct. Importantly, thrombolytic protocols show a possible preventive modality for IC. Finally, while ex vivo machine perfusion technology has gained an interest in DCD liver transplantation, further studies are necessary to evaluate the effectiveness of this evolving field to improve graft quality and transplant outcomes. (Clin Mol Hepatol 2020;26:401-410)

KCI등재 SCOPUS

3Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

저자 : Hyung Joon Yim , Ji Hoon Kim , Jun Yong Park , Eileen L. Yoon , Hana Park , Jung Hyun Kwon , Dong Hyun Sinn , Sae Hwan Lee , Jeong-hoon Lee , Hyun Woong Lee

발행기관 : 대한간학회 간행물 : Clinical and Molecular Hepatology(대한간학회지) 26권 4호 발행 연도 : 2020 페이지 : pp. 411-429 (19 pages)

다운로드

(기관인증 필요)

초록보기

Clinical practice guidelines are important for guiding the management of specific diseases by medical practitioners, trainees, and nurses. In some cases, the guidelines are utilized as a reference for health policymakers in controlling diseases with a large public impact. With this in mind, practice guidelines for the management of chronic hepatitis B (CHB) have been developed in the United States, Europe, and Asian-Pacific regions to suggest the best-fit recommendations for each social and medical circumstance. Recently, the Korean Association for the Study of the Liver published a revised version of its clinical practice guidelines for the management of CHB. The guidelines included updated information based on newly available antiviral agents, the most recent opinion on the initiation and cessation of treatment, and updates for the management of drug resistance, partial virological response, and side effects. Additionally, CHB management in specific situations was comprehensively revised. This review compares the similarities and differences among the various practice guidelines to identify unmet needs and improve future recommendations. (Clin Mol Hepatol 2020;26:411-429)

KCI등재 SCOPUS

4Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease

저자 : Kyung-soo Kim , Byung-wan Lee

발행기관 : 대한간학회 간행물 : Clinical and Molecular Hepatology(대한간학회지) 26권 4호 발행 연도 : 2020 페이지 : pp. 430-443 (14 pages)

다운로드

(기관인증 필요)

초록보기

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder and is associated with various metabolic diseases, including type 2 diabetes mellitus. There are no approved drugs for NAFLD, and the only approved treatment option is weight reduction. As insulin resistance plays an important role in the development of NAFLD, many anti-diabetic drugs have been evaluated for the treatment of NAFLD. Improvement of liver enzymes has been demonstrated by many anti-diabetic drugs, but histological assessment still remains insufficient. Pioglitazone could become the first-line therapy for T2DM patients with NAFLD, based on evidence of histological improvement in patients with biopsyproven nonalcoholic steatohepatitis (NASH). Liraglutide, another promising alternative, is not yet recommended in patients with NAFLD/NASH due to limited evidence. Therefore, well-designed randomized controlled trials should be performed in the near future to demonstrate if and how anti-diabetic drugs can play a role in the treatment of NAFLD. (Clin Mol Hepatol 2020;26:430-443)

KCI등재 SCOPUS

5Managing liver cirrhotic complications: Overview of esophageal and gastric varices

저자 : Cosmas Rinaldi Adithya Lesmana , Monica Raharjo , Rino A. Gani

발행기관 : 대한간학회 간행물 : Clinical and Molecular Hepatology(대한간학회지) 26권 4호 발행 연도 : 2020 페이지 : pp. 444-460 (17 pages)

다운로드

(기관인증 필요)

초록보기

Managing liver cirrhosis in clinical practice is still a challenging problem as its progression is associated with serious complications, such as variceal bleeding that may increase mortality. Portal hypertension (PH) is the main key for the development of liver cirrhosis complications. Portal pressure above 10 mmHg, termed as clinically significant portal hypertension, is associated with formation of varices; meanwhile, portal pressure above 12 mmHg is associated with variceal bleeding. Hepatic vein pressure gradient measurement and esophagogastroduodenoscopy remain the gold standard for assessing portal pressure and detecting varices. Recently, non-invasive methods have been studied for evaluation of portal pressure and varices detection in liver cirrhotic patients. Various guidelines have been published for clinicians' guidance in the management of esophagogastric varices which aims to prevent development of varices, acute variceal bleeding, and variceal rebleeding. This writing provides a comprehensive review on development of PH and varices in liver cirrhosis patients and its management based on current international guidelines and real experience in Indonesia. (Clin Mol Hepatol 2020;26:444-460)

KCI등재 SCOPUS

6Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology

저자 : Silvia Sookoian , Carlos J. Pirola

발행기관 : 대한간학회 간행물 : Clinical and Molecular Hepatology(대한간학회지) 26권 4호 발행 연도 : 2020 페이지 : pp. 461-475 (15 pages)

다운로드

(기관인증 필요)

초록보기

Despite more than two decades of extensive research focusing on nonalcoholic fatty liver disease (NAFLD), no approved therapy for steatohepatitis―the severe histological form of the disease―presently exists. More importantly, new drugs and small molecules with diverse molecular targets on the pathways of hepatocyte injury, inflammation, and fibrosis cannot achieve the primary efficacy endpoints. Precision medicine can potentially overcome this issue, as it is founded on extensive knowledge of the druggable genome/proteome. Hence, this review summarizes significant trends and developments in precision medicine with a particular focus on new potential therapeutic discoveries modeled via systems biology approaches. In addition, we computed and simulated the potential utility of the NAFLD polygenic risk score, which could be conceptually very advantageous not only for early disease detection but also for implementing actionable measures. Incomplete knowledge of the druggable NAFLD genome severely impedes the drug discovery process and limits the likelihood of identifying robust and safe drug candidates. Thus, we close this article with some insights into emerging disciplines, such as chemical genetics, that may accelerate accurate identification of the druggable NAFLD genome/proteome. (Clin Mol Hepatol 2020;26:461-475)

KCI등재 SCOPUS

7Sarcopenia and blood myokine levels as prognostic bio-markers in patients with liver cirrhosis or hepatocellular carcinoma

저자 : Sooyeon Oh , Jooho Lee

발행기관 : 대한간학회 간행물 : Clinical and Molecular Hepatology(대한간학회지) 26권 4호 발행 연도 : 2020 페이지 : pp. 476-479 (4 pages)

다운로드

(기관인증 필요)

초록보기

KCI등재 SCOPUS

8Long-term prognosis and management of hepatocellular carcinoma after curative treatment

저자 : Naoshi Nishida

발행기관 : 대한간학회 간행물 : Clinical and Molecular Hepatology(대한간학회지) 26권 4호 발행 연도 : 2020 페이지 : pp. 480-483 (4 pages)

다운로드

(기관인증 필요)

초록보기

KCI등재 SCOPUS

9Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma

저자 : Jaewhan Song

발행기관 : 대한간학회 간행물 : Clinical and Molecular Hepatology(대한간학회지) 26권 4호 발행 연도 : 2020 페이지 : pp. 484-486 (3 pages)

다운로드

(기관인증 필요)

초록보기

다운로드

(기관인증 필요)

초록보기
권호별 보기
가장 많이 인용된 논문

(자료제공: 네이버학술정보)

가장 많이 인용된 논문
| | | |
1연안해역에서 석유오염물질의 세균학적 분해에 관한 연구

(2006)홍길동 외 1명심리학41회 피인용

다운로드

2미국의 비트코인 규제

(2006)홍길동심리학41회 피인용

다운로드

가장 많이 참고한 논문

(자료제공: 네이버학술정보)

가장 많이 참고한 논문

다운로드

2미국의 비트코인 규제

(2006)홍길동41회 피인용

다운로드

해당 간행물 관심 구독기관

호원대학교 인천대학교 대구한의대학교(구 경산대학교) 중부대학교 국립수목원
 99
 22
 20
 17
 17
  • 1 호원대학교 (99건)
  • 2 인천대학교 (22건)
  • 3 대구한의대학교(구 경산대학교) (20건)
  • 4 중부대학교 (17건)
  • 5 국립수목원 (17건)
  • 6 고려대학교 (16건)
  • 7 연세대학교 (15건)
  • 8 전남대학교 (13건)
  • 9 충남대학교 (12건)
  • 10 영남대학교 (12건)

내가 찾은 최근 검색어

최근 열람 자료

맞춤 논문

보관함

내 보관함
공유한 보관함

1:1문의

닫기